Latest News

The Morning Bull - US Market Morning Update Tuesday, Mar, 24 2026 US stock futures are slightly softer this morning, with key contracts on the S&P 500 and Dow fractionally in the red, as investors weigh mixed global growth signals against stubborn cost pressures. In Europe, Germany's manufacturing PMI sits at 51.7 and France's composite PMI at 48.3, sending a split message where factory activity in one major economy holds up while its neighbor struggles. At the same time, US data shows...

If you are wondering whether Pan African Resources is still good value after its strong run, the starting point is understanding what the current share price actually reflects. The stock closed at £1.256, with recent moves that include a 16.4% decline over 7 days and a 25.2% decline over 30 days, set against a 4.7% year to date return and a very large 1 year gain of 219.9%. These returns sit alongside multi year gains that are also very large over 3 and 5 years. This naturally raises...

One thing we could say about the analysts on Qfin Holdings, Inc. ( NASDAQ:QFIN ) - they aren't optimistic, having just...

Laopu Gold (SEHK:6181) has released its FY 2025 numbers with first half revenue of C¥12.4b and basic EPS of C¥13.38, set against trailing twelve month revenue of C¥27.3b and EPS of C¥28.35 that reflect earnings growth of 230.5% over the past year and an average of 66.3% per year over five years. Over recent periods the company has seen revenue move from C¥3.5b in 1H 2024 to C¥5.0b in 2H 2024 and then to C¥12.4b in 1H 2025, while basic EPS has shifted from C¥4.11 to C¥5.27 and then to C¥13.38,...

China Overseas Grand Oceans Group (SEHK:81) has put fresh numbers on the table for FY 2025, with first half revenue at C¥14.5b and basic EPS of C¥0.08. The trailing 12 month view shows revenue of C¥36.9b and EPS of C¥0.09 as the broader backdrop. Over the past three reported halves, revenue has moved from C¥21.9b in 1H 2024 to C¥24.0b in 2H 2024 and then to C¥14.5b in 1H 2025, with basic EPS shifting from C¥0.25 to C¥0.02 and then C¥0.08. This sets up a mixed picture that investors will weigh...

The recent price decline of 10.0% in Synergy CHC Corp.'s ( NASDAQ:SNYR ) stock may have disappointed insiders who...

Earlier this month, Integra Resources Corp. appointed veteran mining engineer Chantal Lavoie, P.Eng., ICD.D, to its Board of Directors, adding more than 40 years of mine development, operations and governance experience drawn from senior roles at Rio Tinto Iron Ore Company of Canada, Dominion Diamond Corporation, Crocodile Gold Corporation and De Beers Canada. This appointment brings in a director who has overseen large, complex mining businesses across multiple commodities and...

Essex Bio-Technology (SEHK:1061) has opened FY 2025 with first half revenue of HK$876.5 million and basic EPS of HK$0.29, setting the tone for how investors will read the latest set of numbers. The company has seen revenue move from HK$828.5 million in 1H 2024 to HK$858.2 million in 2H 2024 and then HK$876.5 million in 1H 2025, while basic EPS shifted from HK$0.28 to HK$0.26 and then HK$0.29 over the same periods. This gives a clear view of how the top and bottom lines are tracking into the...

Even if it's not a huge purchase, we think it was good to see that Bryan Pinney, the Independent Lead Director of North...

WuXi XDC Cayman (SEHK:2268) has posted FY 2025 results that put the focus squarely on scale, with second half revenue of C¥3.2b and basic EPS of C¥0.60, underpinned by trailing twelve month revenue of C¥5.9b and EPS of C¥1.22. The company has seen revenue move from C¥2.4b in the second half of 2024 to C¥3.2b in the second half of 2025, with basic EPS over that period shifting from C¥0.48 to C¥0.60 as investors weigh a trailing net margin of 24.9% against a slightly lower level a year ago. See...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Earnings event puts Medartis Holding (SWX:MED) in focus Medartis Holding (SWX:MED) is back on investors’ radar after reporting full year 2025 results, with higher sales, net income and earnings per share, followed by a special call on the same day. See our latest analysis for Medartis Holding. At a share price of CHF83.0, the stock has a 1 day share price return of 4.93% but a 30 day share price return that reflects a 12.17% decline. The 1 year total shareholder return of 9.35% suggests...

Healthpeak Properties (NYSE:DOC) has arranged a new $400 million unsecured delayed draw term loan facility. The facility is available on a delayed draw basis, giving the company added flexibility on when to access the capital. This move is designed to strengthen liquidity and support future capital allocation decisions. For REIT investors watching balance sheet strength, this new facility marks a meaningful update for Healthpeak Properties at a time when the shares trade around $17.17. The...

Companhia de Saneamento Básico do Estado de São Paulo - SABESP's ( BVMF:SBSP3 ) recent weak earnings report didn't...

Investors may be considering whether Peoples Bancorp at around US$32 is offering value right now, or if most of the upside has already been taken. The stock has returned 0.6% over the last 7 days and declined 6.0% over 30 days. It is up 6.1% year to date, 11.5% over 1 year, 43.4% over 3 years and 27.5% over 5 years. Recent coverage has focused on Peoples Bancorp as part of broader regional bank discussions and longer term share price performance context. For investors, this backdrop helps...

Q2 2026 earnings snapshot Fonterra Co-operative Group (NZSE:FCG) has just put fresh numbers on the table, with the latest reported quarter showing revenue of NZ$4.4 billion and a basic EPS loss of NZ$0.10, set against a trailing twelve month EPS of NZ$0.62 and revenue of NZ$24.1 billion. Over recent periods the co operative has seen quarterly revenue range from NZ$3.4 billion to NZ$7.1 billion, while basic EPS has swung between a loss of NZ$0.10 and a profit of NZ$0.25, giving investors a...

Synlait Milk (NZSE:SML) has put fresh numbers on the table for H1 2026, with revenue of about NZ$910.6 million and basic EPS of a loss of NZ$0.07, alongside net income of a loss of NZ$44.6 million. The company has seen revenue move from NZ$843.3 million in H2 2024 to NZ$916.8 million in H1 2025 and NZ$910.6 million in H2 2025. EPS has shifted from a loss of NZ$0.39 in H2 2024 to EPS of NZ$0.01 in H1 2025 and back to a loss of NZ$0.07 in H2 2025, presenting a picture where top line scale is...

Wondering whether China Petroleum & Chemical at HK$4.53 still offers value, or if the easy gains are behind it? This article walks through what the current price really reflects. The stock has seen a 5.0% decline over the last 7 days and a 16.3% decline over the last 30 days, yet it shows returns of 15.5% over 1 year, 23.5% over 3 years and 67.3% over 5 years. Recent market conversations around China Petroleum & Chemical have focused on how its share price performance lines up with broader...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

AAON, a US-based HVAC manufacturer backed by two million square feet of lab testing space, has in recent years seen day-to-day expenses rise faster than revenue, driving a 3.7 percentage point reduction in operating margin and a very large annual decline in earnings per share even as sales increased. This tension between growing revenue and shrinking profitability raises fresh questions about how effectively AAON is controlling costs and converting its growing order book into sustainable...

It's shaping up to be a tough period for HELLA GmbH & Co. KGaA ( ETR:HLE ), which a week ago released some...

ProCredit Holding AG ( ETR:PCZ ) shareholders are probably feeling a little disappointed, since its shares fell 4.2% to...

If you are wondering whether Great-West Lifeco's share price still offers value, it helps to start by lining up the current market price against a few different valuation methods. The stock last closed at C$63.21, with returns of a 1.2% decline over 7 days, a 1.0% decline over 30 days, a 5.8% decline year to date, and a 23.4% return over the past year, while the 3 year and 5 year returns stand at 108.9% and 143.3% respectively. Recent share price moves sit against an evergreen backdrop for...

WeRide (NasdaqGM:WRD) has capped FY 2025 with fourth quarter revenue of C¥314 million and a basic EPS loss of C¥1.71, while trailing twelve month figures show revenue of C¥684.6 million and a net income loss of C¥1.65 billion. Over recent quarters, the company has seen revenue move from C¥70.0 million and a basic EPS loss of C¥14.79 in Q3 2024 to C¥140.8 million with a C¥2.43 loss per share in Q4 2024, then to C¥72.4 million and a C¥1.27 loss in Q1 2025 before reaching C¥314 million in Q4...